Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD
Clinical trial NCT02733614 · TERMINATED
Trial details
- NCT number
- NCT02733614
- Sponsor
- Azevan Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2020-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.